About KRG KRG Companies KRG Proffessionals Contact KRG KRG News
About KRG KRG Companies KRG Professionals Contact KRG KRG News

Active
Aurora Diagnostics
Avizent
Cetero Research
Federal
FLSA
Fort Dearborn Company
Interior Specialists, Inc.
Marquette Transportation
OLSON
Liberty Dialysis
PetroChoice
Specialty Finance Co
Tecta America Corp
The Focus Corporation
The MedTech Group Inc.
Tronair Holdings Inc.
UniversalPegasus

Realized Funds
Accellent, Inc.
Aspen Marketing Services
Athletic & Therapeutic Institute
Case Logic
Celebrity, Inc.
Chronic Care Solutions
CIVCO Medical
Instruments Co.
Corporate Training
FMI International
Global Employment Solutions, Inc.
HMS Healthcare, Inc.
Scivex
SPI Manufacturing
SRI
TerraMarc Industries
The Sun Valley Group
The Tensar Corporation
Transcore Holdings
Trinity Hospice, Inc.
Varel International
White Cap

Location Map

Specialty Research, Inc. (SRI) was formed to acquire leading contract research organizations (CRO’s) focused on specialty therapeutic areas such as endocrinology. The first acquisition of SRI, Diabetes & Glandular Disease Research Associates (DGD) specializes in providing Phase I and II/III clinical research investigative services to prominent pharmaceutical and biotechnology companies focused on diabetes, obesity and other endocrine and metabolic therapeutic areas.

Location: Headquartered San Antonio, Texas

Top-Down Strategy: As compounds have grown more complex and high profile disease states such as diabetes, heart disease, and cancer have become more prevalent, specialty CRO’s with significant intellectual capabilities and access to specific study participants (i.e. diabetics) have become increasingly more important to sponsor customers. As a result, endocrine/metabolic clinical trial markets are expected to achieve annual growth in excess of the overall CRO industry.

Buy and Build Strategy: Specialty Research has the potential of becoming an industry leader in the highly fragmented and growing CRO industry by executing a buy and build strategy focused upon the acquisition of other specialty therapeutic CRO’s (diabetes, obesity, hormonal, etc.) while developing best-in-class infrastructure and service capabilities.

Website: www.dgdclinic.com

 



 


KRG Capital Partners • 1515 Arapahoe Street, Tower One Suite 1500 • Denver, Colorado 80202
303.390.5001 • 303.390.5015 fax • info@krgcapital.com